KZA Chart, page-447

Hi Risky

Whilst I tend to believe you are mostly negative on this company, I agree its important to consider all opinions.

As we are in speculation mode I will draw your attention to the last line in Kazia's most recent announcement.


"Kazia expects to receive a final clinical study report in 1Q CY2022 and intends to seek publication of these data in a peer-reviewed scientific journal thereafter."

As you have speculated Milestone 2 could quite possibly be the completion of the phase II. That may not be officially complete until March next year.

As for the current share price malaise. My view is that the market/punters have not taken the time to do the research and fully understand the data provided in the last announcement.